| Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy BM Kluger, LB Krupp, RM Enoka Neurology 80 (4), 409-416, 2013 | 990 | 2013 |
| Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial M Schenkman, CG Moore, WM Kohrt, DA Hall, A Delitto, CL Comella, ... JAMA neurology 75 (2), 219-226, 2018 | 347 | 2018 |
| Palliative care and neurology: time for a paradigm shift I Boersma, J Miyasaki, J Kutner, B Kluger Neurology 83 (6), 561-567, 2014 | 230 | 2014 |
| Nonmotor manifestations of dystonia: a systematic review DJ Kuyper, V Parra, S Aerts, MS Okun, BM Kluger Movement Disorders 26 (7), 1206-1217, 2011 | 204 | 2011 |
| The therapeutic potential of cannabinoids for movement disorders B Kluger, P Triolo, W Jones, J Jankovic Movement disorders 30 (3), 313-327, 2015 | 136 | 2015 |
| Compensatory neural activity in response to cognitive fatigue C Wang, A Trongnetrpunya, IBH Samuel, M Ding, BM Kluger Journal of neuroscience 36 (14), 3919-3924, 2016 | 118 | 2016 |
| Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial BM Kluger, J Miyasaki, M Katz, N Galifianakis, K Hall, S Pantilat, R Khan, ... JAMA neurology 77 (5), 551-560, 2020 | 111 | 2020 |
| Safety of transcranial magnetic stimulation in children: a systematic review of the literature CH Allen, BM Kluger, I Buard Pediatric neurology 68, 3-17, 2017 | 110 | 2017 |
| Parkinson's disease‐related fatigue: a case definition and recommendations for clinical research BM Kluger, K Herlofson, KL Chou, JS Lou, CG Goetz, AE Lang, ... Movement Disorders 31 (5), 625-631, 2016 | 110 | 2016 |
| Neuropalliative care: priorities to move the field forward CJ Creutzfeldt, B Kluger, AG Kelly, M Lemmon, DY Hwang, ... Neurology 91 (5), 217-226, 2018 | 109 | 2018 |
| Parkinson disease patients' perspectives on palliative care needs: What are they telling us? I Boersma, J Jones, J Carter, D Bekelman, J Miyasaki, J Kutner, B Kluger Neurology: Clinical Practice 6 (3), 209-219, 2016 | 101 | 2016 |
| Quadriceps muscle weakness, activation deficits, and fatigue with Parkinson disease J Stevens-Lapsley, BM Kluger, M Schenkman Neurorehabilitation and Neural Repair 26 (5), 533-541, 2012 | 101 | 2012 |
| Palliative care and Parkinson's disease: caregiver perspectives I Boersma, J Jones, C Coughlan, J Carter, D Bekelman, J Miyasaki, ... Journal of palliative medicine 20 (9), 930-938, 2017 | 89 | 2017 |
| Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial WJ Triggs, N Ricciuti, HE Ward, J Cheng, D Bowers, WK Goodman, ... Psychiatry research 178 (3), 467-474, 2010 | 86 | 2010 |
| Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach ZA Macchi, CE Koljack, JM Miyasaki, M Katz, N Galifianakis, LP Prizer, ... Ann Palliat Med 9 (Suppl 1), S24-33, 2020 | 83 | 2020 |
| Fatigue in Parkinson’s disease: report from a multidisciplinary symposium JH Friedman, JC Beck, KL Chou, G Clark, CP Fagundes, CG Goetz, ... NPJ Parkinson's disease 2 (1), 1-6, 2016 | 83 | 2016 |
| Teratogenicity of antiepileptic medications BM Kluger, KJ Meador Seminars in neurology 28 (03), 328-335, 2008 | 82 | 2008 |
| Abnormalities in zinc homeostasis in young infants with cystic fibrosis NF Krebs, JE Westcott, TD Arnold, BM Kluger, FJ Accurso, LV Miller, ... Pediatric research 48 (2), 256-261, 2000 | 79 | 2000 |
| Palliative care for Parkinson’s disease: has the time come? JM Miyasaki, B Kluger Current neurology and neuroscience reports 15, 1-7, 2015 | 78 | 2015 |
| Useful field of view as a reliable screening measure of driving performance in people with Parkinson's disease: results of a pilot study S Classen, DP McCarthy, O Shechtman, KD Awadzi, DN Lanford, ... Traffic injury prevention 10 (6), 593-598, 2009 | 77 | 2009 |
